3D Medicines Market Cap

3D Medicines has a market cap or net worth of 930.01 million as of March 10, 2026. Its market cap has increased by 26.93% in one year.

Market Cap

930.01M

Enterprise Value

526.53M

Revenue

491.34M

Ranking

n/a

PE Ratio

n/a

Stock Price

3.79

Market Cap Chart

Since December 15, 2022, 3D Medicines's market cap has decreased from 7.02B to 930.01M, a decrease of -86.76%. That is a compound annual growth rate of -46.50%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	932.46M	-28.71%
Dec 31, 2025	1.31B	73.29%
Dec 31, 2024	754.73M	-56.44%
Dec 29, 2023	1.73B	-81.75%
Dec 30, 2022	9.49B	35.14%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sunho Biologics	971.95M
Brii Biosciences	995.72M
Transcenta Holding	998.76M
Wuhan YZY Biopharma	1.10B
JW (Cayman) Therapeutics Co.	778.83M
Shanghai Bio-heart Biological Technology	1.20B
Sirnaomics	687.34M
Uni-Bio Science Group	656.84M

Market Cap Rankings